#1 Clinical Trials Search in Europe

Clinical Trials By Country

Explore medical research studies available worldwide

Austria

1000+ trials
100+ centers
Latest trial:
Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Belgium

2000+ trials
200+ centers
Latest trial:
Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Bulgaria

700+ trials
400+ centers
Latest trial:
Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes

Croatia

200+ trials
56 centers
Latest trial:
GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Cyprus

16 trials
5 centers
Latest trial:
A study to evaluate the safety and effectiveness of nucresiran and vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy

Czechia

1400+ trials
500+ centers
Latest trial:
Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes

Denmark

1300+ trials
95 centers
Latest trial:
Study on Cannabidiol for Pain Relief in Patients with Advanced Prostate Cancer

Estonia

100+ trials
44 centers
Latest trial:
BI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases

Finland

500+ trials
99 centers
Latest trial:
Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

France

3900+ trials
800+ centers
Latest trial:
Study on Elranatamab for Patients with Multiple Myeloma Continuing from Previous Clinical Trials

Germany

3300+ trials
1800+ centers
Latest trial:
Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes

Greece

900+ trials
100+ centers
Latest trial:
Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Guadeloupe

2 trials
0 centers

Hungary

1100+ trials
300+ centers
Latest trial:
Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes

Iceland

29 trials
2 centers
Latest trial:
Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

Ireland

400+ trials
42 centers
Latest trial:
Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Israel

0 trials
1 centers

Italy

3400+ trials
500+ centers
Latest trial:
Study of MK-1045 alone or with Tocilizumab in patients with Non‑Hodgkin Lymphoma to evaluate safety and efficacy

Latvia

100+ trials
77 centers
Latest trial:
GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Lithuania

200+ trials
78 centers
Latest trial:
A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Luxembourg

34 trials
4 centers
Latest trial:
Study Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid in Elderly Patients or Those at Risk of Bleeding After Balloon Surgery

Norway

600+ trials
100+ centers
Latest trial:
Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Poland

2500+ trials
1400+ centers
Latest trial:
Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes

Portugal

700+ trials
73 centers
Latest trial:
Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Réunion

2 trials
2 centers
Latest trial:
Study on the Effectiveness and Safety of Chikungunya Vaccine (VLA-1553) for People at Risk of Severe Chikungunya in La Réunion

Romania

700+ trials
400+ centers
Latest trial:
Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

Slovakia

400+ trials
300+ centers
Latest trial:
BI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases

Slovenia

97 trials
26 centers
Latest trial:
RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

Spain

4100+ trials
400+ centers
Latest trial:
Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes

Sweden

900+ trials
100+ centers
Latest trial:
Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

The Netherlands

2100+ trials
200+ centers
Latest trial:
Pumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation

United Kingdom

2 trials
1 centers
Latest trial:
Study of Atropine Sulfate eye drops (0.

United States

1 trials
1 centers
Latest trial:
Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis